当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3801436
自主品牌
已选条件
-
T6126JNJ-7706621JNJ7706621；JNJ 7706621
JNJ-7706621 is a potent aurora kinase inhibitor, and also inhibits CDK1 and CDK2.
价 格：￥电议型 号：T6126产 地：中国大陆
-
T6126JNJ-7706621JNJ-7706621,JNJ7706621,JNJ 7706621
JNJ-7706621 is a potent aurora kinase inhibitor, and also inhibits CDK1 and CDK2.
价 格：￥电议型 号：T6126产 地：美洲
-
T6126JNJ-7706621；化合物JNJ7706621JNJ 7706621；JNJ 7706621
JNJ-7706621 is a potent aurora kinase inhibitor, and also inhibits CDK1 and CDK2.
价 格：￥电议型 号：T6126产 地：中国大陆
-
T405463-Methylthienyl-carbonyl-JNJ-7706621；3-Methylthienyl-carbonyl-JNJ-77066213-Methylthienyl-carbonyl-JN
3-Methylthienyl-carbonyl-JNJ-7706621 is a highly potent and selective inhibitor of cyclin-dependent kinase (CDK). It exhibits impressive IC50 values of 6.4 nM and 2 nM for CDK1/cyclin B and CDK2/cyclin A, respectively. Additionally, 3-Methylthienyl-carbonyl-JNJ-7706621 demonstrates potent inhibition against GSK-3 (IC50 = 0.041 μM) and moderate potency towards CDK4, VEGF-R2, and FGF-R2 (IC50 = 0.11 μM, 0.13 μM, and 0.22 μM, respectively). Its applications in cancer research are noteworthy.
价 格：￥电议型 号：T40546产 地：中国大陆
